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Background: The risk of Plasmodium falciparum malaria increases during pregnancy and at early postpartum.
Immunological and physiological alterations associated with pregnancy that persist after delivery may contribute to
the susceptibility to P. falciparum during early postpartum period.
Methods: To determine changes in antibody-mediated responses after pregnancy, levels of Immunoglobulin G
(IgGs) specific for P. falciparum were compared in 200 pairs of plasmas collected from Mozambican women at
delivery and during the first two months postpartum. IgGs against the surface of erythrocytes infected with a P.
falciparum chondroitin sulphate A binding line (CS2) and a paediatric isolate (MOZ2) were measured by flow
cytometry.
Results: IgG levels against CS2 and MOZ2 were higher at postpartum than at delivery (p = 0.033 and p = 0.045,
respectively) in women without P. falciparum infection. The analysis stratified by parity and period after delivery
showed that this increase was significant in multi-gravid women (p = 0.023 for CS2 and p= 0.054 for MOZ2) and
during the second month after delivery (p = 0.018 for CS2 and p = 0.015 for MOZ2).
Conclusions: These results support the view that early postpartum is a period of recovery from physiological or
immunological changes associated with pregnancy.
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Infections due to several microbial pathogens and auto-
immune diseases have been shown to begin or worsen
during early postpartum period [1]. In particular, the risk
of Plasmodium falciparum malaria increases during preg-
nancy [2] and has been suggested to remain high at early
postpartum compared to the same women during preg-
nancy [3] and to non-pregnant women [4]. However,
other studies have suggested that the rate of parasitaemia
decreases after delivery and that women who were parasi-
taemic at delivery cleared their parasitaemia spontan-
eously at early postpartum [5,6]. Whereas susceptibility* Correspondence: agmayor@clinic.ub.es
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reproduction in any medium, provided the orto malaria during pregnancy has been attributed to lack
of antibodies able to block binding of P. falciparum to
chondroitin sulphate A (CSA) in the placenta [7], little is
known about the anti-malarial immune responses of
women during the first months after delivery.
It has been suggested that immunity is altered during
pregnancy to promote tolerance to foetal antigens [8].
Maintenance of an essentially type 2 cytokine environ-
ment, modulation of lymphocyte responses and redistribu-
tion of regulatory T cells (reviewed in [1]) appear to be
essential for a successful pregnancy. It has been speculated
that the period of recovery from immunological and
physiological alterations associated with pregnancy may
still render puerperal women susceptible to malaria [3].
There is lack of information on the dynamics of anti-
bodies against P. falciparum during early postpartum
[9-11]. The aim of the present study was to determinetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Mayor et al. Malaria Journal 2012, 11:130 Page 2 of 6
http://www.malariajournal.com/content/11/1/130changes in the level of antibodies against P. falciparum
during the first two months postpartum that may sug-
gest alterations of humoral immunity during pregnancy
[1]. To address this, immunoglobulin G (IgG) levels
against the surface of P. falciparum-infected erythro-
cytes were compared in paired samples collected at de-
livery and postpartum of the same women, taking into
consideration the effect of placental infection, parity,
HIV infection and postpartum period.
Methods
Study area and population
The study was conducted at the Centro de Investigação
em Saúde de Manhiça (CISM) in Manhiça District,
southern Mozambique, between 2003 and 2005. Malaria
transmission is perennial with some seasonality [12].
During the study, intermittent preventive treatment dur-
ing pregnancy (IPTp) with sulphadoxine-pyrimethamine
(SP) was not yet recommended by the Ministry of Health
and malaria control in pregnancy relied exclusively upon
case management.
Study design
This study was conducted in the context of a rando-
mized, double blind, placebo-controlled trial of IPTp
with SP (trial registration number: NCT00209781) [13].
Women enrolled into the study received a long-lasting
insecticide-treated net and were randomized to receive
two placebo or SP doses from the second trimester, at
least one month apart. At the time of delivery and four
to eight weeks later, thin and thick smears were prepared
and examined for malarial parasites according to quality-
control procedures [14]. Peripheral blood was collected
into EDTA vacutainers, centrifuged and plasma was
stored at −20°C. Blood samples from the placenta and
periphery of pregnant women at delivery, as well as at
postpartum, were collected onto filter papers (Schleicher
& Schuell number 903TM). Placental biopsies from the
maternal side of the placenta were collected for histo-
logical examination [13]. The last 200 women recruited
in the main trial (n = 1030) with all demographic data
and available plasma and filter papers from both delivery
and postpartum were included in this study.
Written informed consent was obtained from all study
participants. Malaria clinical episodes were treated fol-
lowing national guidelines at the time of the study. The
study was approved by the national Mozambican ethics
review committee and the Hospital Clínic of Barcelona
ethics review committee.
Plasmodium falciparum detection by PCR
DNA was extracted from a blood drop of 50 μl onto filter
paper with an ABIPrism 6700 automated nucleic acid work
station (Applied Biosystems) and finally re-suspended in200 μl water. Five μl of sample were screened for P. fal-
ciparum DNA by real-time quantitative PCR (qPCR)
[15].
Measurement of antibody responses against the surface
of infected erythrocytes
The chondrointin sulphate A (CSA)-binding strain CS2
[16] (MRA-96, MR4, ATCCW, Manassas, VA) and a
Mozambican paediatric non-CSA-binding isolate (MOZ2)
[15] were cultured under standard conditions, synchro-
nized at ring stage and cryopreserved in multiple aliquots
at a parasitaemia of 1–3 %, until used for antibody deter-
minations. Matched plasma samples from women at deliv-
ery and postpartum were tested in the same experiment
for recognition of CS2 and MOZ2 by flow cytometry, as
previously described [15]. To minimize inter-assay varia-
tions, all the experiments were conducted with different
aliquots of the same batch of cryoperserved ring-stage
parasites. Parasites were thawed, matured to trophozoite
and re-suspended at 1 % haematocrit. The suspensions of
infected erythrocytes were sequentially incubated with
test plasma at 1:20 dilution, polyclonal rabbit anti–human
IgG (DakoCytomation; dilution 1:200) and AlexaFluor
donkey anti–rabbit IgG (Invitrogen; dilution 1:1000) plus
10 μg/mL of ethidium bromide. Data from 1000 events in
the channel for ethidium bromide–labelled erythrocytes
were acquired with a Becton-Dickinson FACSCalibur flow
cytometer. Reactivity against the surface of infected ery-
throcytes was expressed as the difference between the
mean fluorescence intensity (MFI) of infected erythro-
cytes and the MFI of uninfected erythrocytes.
Definitions and statistical methods
Peripheral infection at delivery and postpartum was
defined as the presence of parasite DNA detected by
qPCR. Placental infection was defined as the presence of
parasites detected by qPCR or the presence of only pig-
ment observed by histology (past infection). Women
were classified as primigravidae (PG) if they were preg-
nant for the first time, secundigravidae (SG) if they were
in their second pregnancy and multigravidae (MG) if
they reported at least two previous pregnancies. Postpar-
tum periods were defined as early if the blood sample
was collected during the first 30 days after delivery, or
late if the sample was collected during the second month
post-delivery. Proportions and continuous variables be-
tween independent groups were compared by the
Fisher´s exact and Mann Whitney’s test, respectively.
Wilcoxon rank sum test was used for pair-wise compari-
sons of levels of IgGs (MFI values) in samples at delivery
and postpartum from the same women. A p-value <0.05
was considered statistically significant. Data analysis was
performed using Stata 11 (Stata Corporation, College
Station, TX, USA).
Table 1 IgG levels against the surface of erythrocytes
infected with the parasite lines CS2 and MOZ2, by
infection at postpartum
Postpartum - Postpartum +
Median IQR Median IQR p
All women (n=200)
CS2 78.9 28.4-305.9 526.9 163.4-766.1 <0.001
MOZ2 45.8 23.8-83.6 83.3 49.2-127.6 0.007
Women without placental infection (n =98)*
CS2 47.4 22.4-184.5 53.3 39.2-104.5 0.845
MOZ2 36.4 19.3-62.4 44.6 17.6-52.0 0.991
IQR: Inter-quartile range.
* Analysis excluding women with placental malaria to rule out the boosting of
antibodies by infection at delivery.
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Characteristics of the study women
Among the 200 women included in the study, 50 (25 %)
were PG, 37 (19 %) SG, and 113 (56 %) MG; median age
was 23 years (interquartile range [IQR] 19–28); 50
women (25 %) were HIV positive and 100 (50 %) had
received IPTp with SP. Overall, they were comparable
with the 1,030 total women participating in the rando-
mized trial [13] in terms of IPTp intervention, parity and
age (all p-values> 0.306). By microscopy, 16 (8 %)
women were infected in their peripheral blood at deliv-
ery and eight (4 %) at postpartum. qPCR detected infec-
tions in 48 (24 %) placental blood samples, 55 (27 %)
peripheral samples and 20 (10 %) postpartum samples.
Thirty-seven (19 %) women were infected at delivery in
both peripheral blood and placenta, 18 (9 %) only in per-
ipheral blood and 11 (6 %) only in the placenta. Histo-
logical examination of the placental sections showed the
presence of 24 (12 %) P. falciparum active infections (13
with only parasites and 11 with both parasites and hae-
mozoin) and 68 (34 %) past infections Among these 24
placentas with active infection, six were negative by
qPCR (five acute and one chronic infection). Histological
examination of the 152 placentas that were negative by
qPCR showed that 93 were negative both for parasite
and pigment, 53 had pigment, five only parasites and
one both parasites and pigment. Overall, there was no
evidence of parasite by qPCR nor pigment by histology
in 98 (49 %) of the placentas.
Among the 200 postpartum samples, 39 (19 %) were
collected during the first month after delivery (early
postpartum) and 161 (81 %) during the second month
post-delivery (late postpartum). Proportion of MG was
similar among early (21/36 [58 %]) and late postpartum
women (80/144 [56 %]; p = 0.852) and among HIV nega-
tive (84/150 [56 %]) and positive women (29/50 [58 %];
p = 0.302).Effect of Plasmodium falciparum infection at postpartum
on IgG levels
Infection at postpartum was associated with higher levels
of IgGs against CS2 and MOZ2, compared to levels in
women without infection (Table 1). As infection during
postpartum is highly associated with infection at delivery
[17], and to check for the possibility that higher levels of
IgGs after delivery may be due to the boosting of anti-
body responses by placental infection [18], IgG levels by
postpartum infection were compared among women
with no detectable active or past placental infection
(n = 98). In the absence of placental infection, no associ-
ation was found between postpartum infection and
increased level of IgGs against the surface of IEs
(Table 1).IgG levels at delivery and postpartum
Levels of IgGs specific for CS2 and MOZ2 were higher
at postpartum than at delivery in 115 (58 %) and 120
(60 %) of the 200 women, respectively (Table 2). The
paired analysis showed that levels of IgGs against MOZ2
increased at postpartum compared to delivery
(p = 0.001), and a similar trend was found for IgGs
against CS2 (p = 0.054) (Table 2). Analysis stratified by
parity, postpartum period, HIV status and intervention
showed that this difference was significant in MG
women (CS2 and MOZ2), at late postpartum (MOZ2), in
women who received IPTp (CS2 and MOZ2; differences
for MOZ2 were also observed among women who
received placebo), and in HIV-negative women (MOZ2;
Table 2). To check for the possibility that increased levels
of antibodies at postpartum might be due to the boosting
effect of P. falciparum infections either in the placenta
or at postpartum, IgG levels among women without evi-
dence of infection (n = 95) were also compared between
delivery and postpartum (Table 2). This analysis con-
firmed that postpartum was associated with higher levels
of antibodies against both parasite lines among women
without evidences of placental infection during preg-
nancy. The analysis stratified by parity and postpartum
period showed differences in MG women (statistically
significant for CS2 and a trend for MOZ2) and at late
postpartum (Table 2). No consistent pattern was found
for HIV infection, since IgG levels were higher at post-
partum than at delivery both among HIV-negative (CS2)
and among HIV-infected women (MOZ2; Table 2).Discussion
The importance of pregnancy-associated malaria does
not end at delivery, as the postpartum period is sug-
gested to be also a time of additional vulnerability to P.
falciparum [3,4]. However, the causes of increased sus-
ceptibility to malaria at postpartum remain to be
explained. This study shows that antibody responses
Table 2 Number of women with a positive or negative difference in IgG levels between postpartum and delivery, and
magnitude of the difference
All (n = 200) Placenta and postpartum negative (n = 95)
n>0 n<0 Difference p




CS2 115 85 5.8 0.054 57 38 6.1 0.033
MOZ2 120 80 9.8 0.001 56 39 10.0 0.045
By parity
Primigravidae
CS2 24 26 4.7 0.828 9 9 −1.4 0.557
MOZ2 31 19 8.3 0.121 12 6 21.3 0.349
Secundigravidae
CS2 20 17 0.8 0.886 9 7 3.5 0.351
MOZ2 21 16 6.7 0.213 7 9 −0.1 0.569
Multigravidae
CS2 71 42 13.9 0.015 39 22 18.4 0.023
MOZ2 68 45 10.4 0.009 37 24 10.0 0.054
By postpartum period
Early
CS2 24 15 19.1 0.116 9 10 −3.5 0.904
MOZ2 22 17 17.7 0.357 8 11 −0.1 0.658
Late
CS2 91 70 3.3 0.197 48 28 6.9 0.018
MOZ2 98 63 8.8 0.002 48 28 12.4 0.015
By IPTp
Placebo
CS2 57 43 7.5 0.511 27 19 9.0 0.145
MOZ2 58 42 10.2 0.029 25 21 8.8 0.195
SP
CS2 58 42 4.1 0.047 30 19 3.6 0.106
MOZ2 62 38 9.2 0.015 31 18 10.0 0.130
By HIV status
Negative
CS2 90 60 8.5 0.101 48 29 7.6 0.029
MOZ2 88 62 7.6 0.008 44 33 10.0 0.204
Positive
CS2 25 25 −1.1 0.527 9 9 −1.1 0.879
MOZ2 32 18 16.7 0.069 12 6 15.9 0.035
a Wilcoxon rank sum tests for pair-wise comparisons between MFIs for CS2 and MOZ2 at delivery and postpartum.
n>0 indicates the number of women with IgG levels higher at postpartum than at delivery and n<0 the number of women with IgG levels lower at postpartum
than at delivery.
Difference (%) denotes the median difference in IgG levels between postpartum and delivery samples expressed in % of levels at delivery.
PG, primigravidae; SG, secundigravidae; MG, multigravidae; IPTp, intermittent preventive treatment in pregnancy; SP, sulphadoxine-pyrimethamine.
Analysis including all women and only those without infection were stratified by parity, postpartum period, HIV status and IPTp administration.
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are higher at postpartum than in the same women at de-
livery. This increase was observed both for IgGs against
a paediatric isolate and a CSA-binding line, suggestingthis is a general phenomenon not-specifically related to
placental parasites.
These results are not contradictory to previous reports
showing waning of antibodies against CSA-binding
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bodies are expected to naturally decay with time in ab-
sence of exposure to placental-type parasites. Another
study conducted among primigravidae Ghanaian women
showed that antibody levels against the surface of
infected erythrocytes tended to increase from second tri-
mester to six weeks postpartum [11], although this in-
crease was not confirmed in other studies [9,10]. In the
same direction, IgGs against Pf155/RESA was shown to
increase at postpartum among primigravidae women
from Cameroon [20]. The reason for these contradictory
results may be owing to differences in the sampling
time-points during postpartum, the parity groups
included in the study, the prevalence of infection at de-
livery that boosts antibody responses, as well as the stat-
istical methods used to analyse the data. Also, as
previously suggested [20], the regulation of antibody pro-
duction and the triggering of antibody-secreting cells at
delivery and postpartum may depend on the specificity
of the antigen.
The increase of antibodies after delivery observed in
this study can be partially explained by the boosting of
antibodies associated with placental or postpartum infec-
tions that may increase IgGs levels postpartum. Women
who received IPTp with SP (being at reduced risk of in-
fection during pregnancy because of the intervention
and thus expecting a lower boosting of antibodies) had
lower antibody levels specific for CS2 at delivery com-
pared to postpartum. However, such a difference was not
observed in women who received placebo, suggesting
that other factors apart from the boosting of antibodies
at delivery might contribute to the increase of antibodies
at postpartum. Lower levels of IgGs at delivery might be
explained by expansion of plasma volume in pregnant
women. However, it has been shown that, similar to
observations from the current study, geometric mean
titres of antibodies against herpes simplex virus and
measles declined during pregnancy and returned to ini-
tial values by the end of the postpartum, even after tak-
ing into account the effect of haemodilution [21]. These
observations, together with other studies showing that
several macromolecules in plasma, such as α2-macroglu-
bulins, do not change during pregnancy [22], suggest
that the contribution of plasma expansion to the increase
of antibodies after delivery may be small. Finally, preg-
nancy-associated immuno-modulation affecting humoral
responses might also contribute to the lower level of
antibodies at delivery compared to postpartum.
Contradictory results about the effect of pregnancy on
the humoral immune system have been reported. Some
studies have suggested that the maternal immune system
may tolerate foetal antigens by suppressing cell-mediated
immunity while retaining normal humoral immunity [8].
However, lower antibody levels against specific infectiousagents in pregnant versus non-pregnant women have
also been described [21,23-25], as well as reductions in
other antibodies during pregnancy [26-29]. Results from
the current study suggest that pregnancy does not impair
acquisition of antibodies against pathogens [30], as
shown by the boosting of anti-malarial antibodies asso-
ciated with P. falciparum infection. However, one may
speculate that antibody responses may decline during
pregnancy in the absence of antigenic stimulation, espe-
cially if the activity of the cells involved in the production
of antibodies is modulated by pregnancy-associated fac-
tors. This latter interpretation may be supported by the
observed increase in antibody responses after delivery at
late postpartum (i.e. immunity takes some time to recover
after delivery) and among MG women (i.e. PG may need
more time to restore their basal levels of antibodies).
This study has three important limitations. First, the
study focused on the analysis of antibodies against the
surface of infected erythrocytes, which are known to
have a key role in the development of anti-malarial im-
munity during pregnancy [7], but limitations of plasma
volume did not allow to measure IgGs against other P.
falciparum antigens or total antibodies. Second, compar-
isons stratified by parity and postpartum period should
be taken with caution due to a reduction of the power of
the analysis. And finally, it was not possible to assess the
clinical relevance of the increase in antibodies after deliv-
ery, given the lack of knowledge on the precise immune
mechanisms mediating protection against malaria in
pregnancy and the levels needed to achieve this
protection.
Conclusions
Results of this study support the view of early postpar-
tum (i.e. the first month after delivery) as a period in
which the level of anti-malarial antibodies gradually in-
crease after delivery, possibly due to recovery from preg-
nancy-associated physiological and immune changes
[1,8]. These re-adjustments might still render women
susceptible to new malaria infections and/or allow para-
sites infecting pregnant women to persist during the
early postpartum period [4]. Further studies are needed
to understand the mechanisms whereby immunity may
recover at postpartum and the implications on resistance
to P. falciparum.
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